David Crow, the senior U.S. business correspondent at the Financial Times who has been primarily covering the pharma beat, has been named its banking editor and will be moving to London next month.
On Twitter, Crow wrote, “Very excited about the new opportunity, but sad to say goodbye to the pharma beat. Thanks to everyone who helped me try to do it justice.”
Crow has been the senior U.S. business correspondent for the past four years. He joined the FT in June 2012 as an assistant news editor and held that spot until September 2014.
He previously was the managing editor and head of news at City A.M. in London. He previously was the politics editor at City A.M.
Crow also worked as a media and technology writer for The Spectator. He holds a bachelor’s degree from the University of Glasgow.
